In the field of medical diagnostics, efficiency and accuracy are the lifelines of clinical treatment. However, as the population ages and demand for chronic disease management surges, the limitations of traditional coagulation laboratories are becoming increasingly apparent: bulky equipment, lengthy testing processes, heavy dependence on manual labor, and insufficient capability to handle complex cases. These issues not only lead to sample backlog and report delays but also risk missing critical treatment windows for emergency and severe cases. So, how can diagnostic efficiency be elevated in high-demand, high-pressure medical environments?

Innovation in R&D Enhances Diagnostic Efficiency

Before entering the market, medical devices in China must pass rigorous review by the National Medical Products Administration (NMPA), with the designation of 'innovative medical device' being particularly stringent. Core technologies must demonstrate novelty and originality, be domestically unprecedented in principle or mechanism, reach internationally advanced levels, show substantial improvements in performance or safety compared to traditional products, and offer significant clinical application value. Due to the extremely low approval rate, such certifications draw great industry attention.

Space series Automatic Blood Coagulation Analyzer, independently developed by Beijing ZONCI Technology Development Co., Ltd., represent high-end innovation in coagulation testing. With its leading-edge technology, the product has been recognized as an 'Innovative Medical Device'. It features an industry-first vertical dual-unit design, occupying just 0.85 square meters, delivering exceptional testing throughput in minimal space. Its dual AB systems can operate independently or in tandem, enabling uninterrupted high-throughput processing — earning its reputation as the ultimate standalone analyzer.

Revolutionizing Automation Through Spatial Redesign

Traditional coagulation analyzers are often bulky, occupying several square meters of lab space. Combined with reliance on manual operations, this results in sample backlogs and delayed report cycles, making them ineffective in meeting urgent care or mass screening needs.

ZONCI’s Space series Automatic Blood Coagulation Analyzers are built around two core principles: 'space intensification' and 'full process automation', successfully breaking through traditional spatial and efficiency limitations of clinical laboratories.

Compared to conventional analyzers, the Space1 occupies only 0.85 m² but delivers a processing capacity of 1300 tests per hour (Ts/h), doubling the efficiency of traditional systems. In double Space1 analyzer mode, it reaches 2600 Ts/h in under 4 m². With five Space 1 analyzer worked together, 6500 Ts/h can be achieved in under 7 m² — a leap in diagnostic throughput.

The Space1 analyzer inherits ZONCI’s smart, user-friendly interface design, equipped with a dual-track synchronized intelligent lift system and 360° auto-sample barcode scanning. It supports batch sample overall testing and fully automates the entire workflow from sample input to report output. This not only drastically improves sample processing efficiency within limited space but also secures valuable 'golden time' for emergency and critical care patients.

The closed-loop ecosystem empowers the implementation of precision medicine

The population aged over 60 in China has exceeded 300 million. Elderly patients generally face challenges in diagnosis and treatment such as coexistence of multiple diseases and complex blood coagulation conditions. Traditional detection equipment has problems such as single detection items, complex operation and delayed reports, which are difficult to meet the precise needs of individualized anticoagulation therapy. Primary hospitals may find it difficult to effectively meet the demands of chronic disease management due to high equipment procurement costs and high technical operation thresholds.

Zhongchi Weiye's "equipment + reagents + informatization" closed-loop ecological solution can precisely respond to the differentiated needs of medical institutions at all levels and provide matching solutions, significantly enhancing the laboratory's diagnostic capabilities for complex coagulation conditions in the elderly: Relying on the automated process to significantly reduce the reporting time, it not only meets the urgent demand for timeliness in the emergency scenario, but also adapizes to the long-term monitoring scenario of chronic diseases through dynamic data tracking. The multi-dimensional detection items construct a complete coagulation function assessment system, providing full-chain data support for individualized antithrombotic/anticoagulation treatment and assisting doctors in formulating precise diagnosis and treatment strategies. The modular equipment design and the intensive reagent menu form a "light asset" construction model, empowering grassroots hospitals to quickly build standardized coagulation testing platforms at a lower cost and promoting the optimal allocation of medical resources.

With continuous technological innovation, Zhongchi Weiye is becoming a core driver for upgrading the efficiency of coagulation laboratories in an aging society, facilitating the transformation of clinical practice from "disease treatment" to "comprehensive health management".

The development of the medical testing industry has always been accompanied by a deep resonance between technological breakthroughs and clinical demands. Zhongchi Weiye will continue to drive efficient development through innovation, focus on the field of medical testing, and provide more advanced medical testing equipment for hospitals at all levels.